Aspira Women’s Health (AWH) announced it has named Jody Berry, Ph.D. as its new Chief Scientific Officer. Dr. Ryan Phan, who stepped down as the Company’s Chief Scientific and Operating Officer, remains as an advisor through the end of the year to help with the transition and provide scientific and operational advice related to ongoing product development programs. Dr. Jody Berry joins Aspira from OraSure Technologies (OSUR), where he served as Chief Science Officer responsible for all innovation and product development including the breakthrough discovery of the first integrated swab test for COVID-19.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AWH:
- Aspira Women’s Health signs sample procurement agreement University of Oxford
- Aspira Women’s Health Signs Exclusive Sample Procurement Agreement with The University of Oxford
- Aspira appoints Michelle Snider as SVP, commercial strategy, operations
- Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
- Aspira Women’s Health initiated with a Buy at Alliance Global Partners
